EDWARD UNKART is listed as a director on 6 SEC Form D filings by 3 issuers between Feb 2011 and Mar 2015: TRIA Beauty, Inc. (Dublin, CA — other health care — 2011–2013; $40.5M reported sold to 38 investors), ALTERG INC (Fremont, CA — other health care — 2012; $10.3M reported sold to 16 investors) and Carbylan Therapeutics, Inc. (Palo Alto, CA — other health care — 2015; $6M reported sold to 4 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $56.8M sold in total.
Listed alongside Albert Cha (5 shared filings), David Mauney (4 shared filings), HARVEY LIU (4 shared filings), JAMES GLASHEEN (4 shared filings), KEVIN J. APPELBAUM (4 shared filings) and 30 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around EDWARD. Each name links to their own page.
1 of the issuers belongs to the sponsor group Tria (2 issuers, $10M reported sold, 2010–2014).
What this means A sponsor group is one team that sets up a new company for each deal. Tria has 2 companies on file and $10M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 6 public filings for EDWARD UNKART and found 6 differences: Form D filed 35 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.